Candriam S.C.A. Bluebird Bio, Inc. Transaction History

Candriam S.C.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$18.04 - $22.09 $7.63 Million - $9.35 Million	-423,098 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$16.59 - $33.89 $265 - $542	-16 Reduced -0.0%	423,098 $17.6 Million
Q4 2020 Jan 22, 2021	BUY	$27.5 - $37.92 $2.57 Million - $3.54 Million	93,468 Added 28.35%	423,114 $18.3 Million
Q3 2020 Oct 19, 2020	SELL	$34.44 - $43.75 $3.02 Million - $3.84 Million	-87,702 Reduced 21.01%	329,646 $17.8 Million
Q2 2020 Jul 23, 2020	BUY	$27.12 - $45.97 $4.87 Million - $8.25 Million	179,489 Added 75.46%	417,348 $25.5 Million
Q1 2020 May 26, 2020	BUY	$26.16 - $63.5 $444 - $1,079	17 Added 0.01%	237,859 $20.4 Million
Q4 2019 Jan 21, 2020	BUY	$46.96 - $61.67 $3.23 Million - $4.24 Million	68,742 Added 40.65%	237,842 $21,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $3.87 Million - $6.11 Million	65,500 Added 63.22%	169,100 $16.8 Million
Q3 2018 Nov 07, 2018	BUY	$88.86 - $117.49 $3.38 Million - $4.46 Million	38,000 Added 57.93%	103,600 $15.1 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $2.85 Million - $3.65 Million	28,600 Added 77.3%	65,600 $10.3 Million
Q1 2018 May 09, 2018	SELL	$105.8 - $150.94 $529,000 - $754,700	-5,000 Reduced 11.9%	37,000 $6.32 Million
Q4 2017 Feb 07, 2018	SELL	$81.25 - $130.7 $1.3 Million - $2.09 Million	-16,000 Reduced 27.59%	42,000 $7.48 Million
Q3 2017 Nov 03, 2017	BUY	$57.74 - $91.42 $3.35 Million - $5.3 Million	58,000	58,000 $7.97 Million

151

64.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27.8M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.